On this page

What are the Fallopian Tubes?
What is Salpingitis?
Causes
Symptoms
Complications
Diagnosis
Treatment
Prevention
Sources and Bibliography

What are the Fallopian Tubes?

The Fallopian tubes, also known as salpinges or uterine tubes, are two hollow, muscular conduits that extend from the uterus, one on each side, opening near the corresponding ovary. Each tube is approximately 10–12 cm long and plays a fundamental role in human reproduction.

Each month during a woman’s fertile years, an egg (oocyte) is released from one of the two ovaries (ovulation) and enters the corresponding Fallopian tube. Tiny hair-like projections called cilia line the inner surface of the tube and create a gentle sweeping motion that guides the egg toward the uterus over the course of several days.

The Fallopian tube is also the site of fertilization: during unprotected sexual intercourse, sperm travel up through the uterus and into the tube, where they may meet and fertilize the descending egg. The resulting embryo then continues its journey to the uterus, where it implants in the endometrium and develops into a pregnancy.

The structural and functional integrity of the Fallopian tubes is therefore absolutely essential for natural conception.

What is Salpingitis?

Salpingitis is the inflammation of one or both Fallopian tubes, almost always caused by a bacterial infection. It is one of the most clinically significant manifestations of pelvic inflammatory disease (PID), a broader term encompassing infections of the female upper genital tract (uterus, tubes, and ovaries).

When the Fallopian tube becomes infected and inflamed:

The tube’s inner lining swells and secretes fluids
Pus (a mixture of white blood cells, bacteria, and dead tissue debris) may accumulate within the tube lumen
The infection can rapidly spread bilaterally, from one tube to the other, via shared lymphatic vessels. This means that what begins as a unilateral infection (salpingitis of one tube) frequently becomes bilateral salpingitis within a short period

Salpingitis is one of the leading causes of female infertility. Without timely and adequate treatment, the infection can cause permanent structural damage to the tube, including the formation of internal scar tissue (adhesions) and blockage (occlusion) of the tube lumen. This prevents the normal passage of eggs and sperm, rendering natural conception impossible. Tubal scarring and occlusion are the most frequent and feared long-term complications of pelvic inflammatory disease.

Acute vs. Chronic Salpingitis

Acute salpingitis: sudden onset with more pronounced inflammatory response; can rapidly lead to serious complications if untreated
Chronic salpingitis: typically follows an incompletely treated acute episode. It is generally milder and often completely asymptomatic, yet persistently damaging. This makes it particularly dangerous because the patient may not seek treatment until complications have already developed

A Critical Warning

There is a poor correlation between symptom severity and the degree of tubal damage. Infections caused by certain organisms, most notably Chlamydia trachomatis, are frequently entirely silent (no symptoms whatsoever) yet can cause severe, permanent tubal damage and infertility. This is one of the most compelling arguments for regular STI screening in sexually active women.

Causes

In the vast majority of cases, salpingitis is caused by a bacterial infection, most commonly sexually transmitted:

Primary Bacterial Pathogens

Organism	Disease Caused	Notes
Chlamydia trachomatis	Chlamydia	Most common STI-related cause; frequently asymptomatic; responsible for a large proportion of tubal-factor infertility
Neisseria gonorrhoeae	Gonorrhea	Second most common; often co-exists with chlamydia; typically produces more acute symptoms
Mycoplasma genitalium	Mycoplasma infection	Increasingly recognized as an important cause; often resistant to standard antibiotics
Staphylococcus spp.	Staphylococcal infection	Non-sexually transmitted; may follow procedural contamination
Streptococcus spp.	Streptococcal infection	May occur after childbirth, miscarriage, or surgical procedures
Polymicrobial (mixed flora)	Mixed infection	Common in PID; often involves anaerobic bacteria in combination with STI pathogens

Route of Infection

The typical pathway of infection begins in the vagina or cervix (the lower genital tract). If the initial infection is not recognized and treated:

Bacteria ascend through the uterine cavity
They reach the Fallopian tubes via the uterine openings (uterotubal junctions)
The infection spreads to the ovaries and surrounding pelvic structures (tubo-ovarian complex)

Non-Sexual Routes of Infection

While sexual transmission is by far the most common route, salpingitis can also occur following:

IUD (intrauterine device) insertion: the procedure can introduce vaginal flora into the uterine cavity; the risk is highest in the first 3 weeks after insertion
Voluntary termination of pregnancy (abortion) or spontaneous miscarriage
Childbirth: postpartum endometritis can ascend to involve the tubes
Appendicitis: infection from a ruptured appendix can spread directly to the adjacent right Fallopian tube

Who Is at Risk?

While salpingitis can affect women of any age, it is most common in sexually active women of reproductive age (15–35 years). Specific risk factors include:

Multiple sexual partners
New sexual partner within the preceding 3 months
Prior episode of PID or STI
Young age (adolescents are at particularly high biological risk due to cervical ectopy)
Absence of barrier contraception use
Recent intrauterine procedure
Douching (disrupts the protective vaginal microbiome)

Symptoms

The clinical presentation of salpingitis ranges from completely asymptomatic to severe systemic illness, and this variability represents one of the major diagnostic and management challenges.

The “Silent” Infection Problem

Many cases, particularly those caused by Chlamydia trachomatis, produce few or no symptoms. The absence of symptoms does not indicate a mild or harmless infection: silent salpingitis can cause the same degree of permanent tubal damage as symptomatic disease. This is why regular STI screening (regardless of symptoms) is a critical tool for protecting reproductive health.

Common Symptoms

When symptoms are present, they may include one or more of the following:

Pelvic pain: the most characteristic symptom. It is typically bilateral, though it may be predominantly unilateral, and ranges from a dull ache to severe, debilitating pain
Abnormal vaginal discharge: changes in color (yellow, green, gray), consistency, or odor. A purulent (pus-like) discharge is strongly suggestive of infection
Intermenstrual bleeding (spotting): bleeding between normal menstrual periods
Dysmenorrhea: abnormally severe pain during menstruation
Mid-cycle pain: pain at ovulation (mittelschmerz), potentially worsened by tubal inflammation
Dyspareunia: pain during sexual intercourse, particularly with deep penetration
Fever: typically low-grade in mild cases. High fever suggests a more severe infection or abscess formation
Abdominal pain may be diffuse or localized to the lower abdomen
Lower back pain referred from pelvic structures
Urinary frequency due to the anatomical proximity of the bladder to the inflamed pelvic organs
Nausea and vomiting (more common in severe cases)

Seek medical attention promptly if you experience persistent pelvic pain, unusual vaginal discharge, fever, or pain during sex, particularly if you are sexually active and have not been recently tested for STIs. Early treatment significantly reduces the risk of permanent reproductive consequences.

Complications

Without timely and appropriate treatment, salpingitis can lead to a spectrum of serious complications, some of which are life-threatening and others permanently life-altering:

1. Spread to Adjacent Pelvic Organs

Infection can extend from the Fallopian tubes to involve the ovaries (oophoritis), the uterus (endometritis), the peritoneum (peritonitis), and in extreme cases, the liver surface (Fitz-Hugh-Curtis syndrome: perihepatitis causing right upper quadrant pain). This progression constitutes full-blown pelvic inflammatory disease (PID).

2. Tubo-Ovarian Abscess (TOA)

When infection becomes walled off and pus accumulates within the ovary and tube, a tubo-ovarian abscess forms. TOA is a serious condition requiring:

Hospital admission
Prolonged intravenous antibiotic therapy
Drainage (percutaneous or surgical) if the abscess does not respond to antibiotics
Emergency surgery if rupture occurs, causing life-threatening peritonitis and sepsis

3. Ectopic Pregnancy

Ectopic pregnancy (implantation of the fertilized egg outside the uterus, most commonly within a Fallopian tube) is among the most dangerous complications of salpingitis. It occurs because:

Scar tissue and damage to the cilia impair the normal transport of the fertilized egg through the tube
The embryo, unable to reach the uterus, implants and begins to develop within the narrow tube
The tube cannot expand sufficiently to accommodate the growing embryo
Without early detection and treatment, tubal rupture occurs, causing severe internal hemorrhage, a potentially fatal emergency

Ectopic pregnancy is a leading cause of maternal mortality in the first trimester of pregnancy. Any woman with a history of salpingitis or PID who becomes pregnant should be closely monitored with early transvaginal ultrasound to confirm intrauterine implantation.

4. Infertility

Scarring, fibrosis, and occlusion of the Fallopian tubes following salpingitis can permanently impair or eliminate the possibility of natural conception. A single episode of PID increases the risk of subsequent infertility by approximately 10–15%; after three or more episodes, the risk exceeds 50%. This is one of the most significant preventable causes of infertility in women worldwide.

5. Chronic Pelvic Pain

Persistent pelvic pain, which lasts 6 months or more, can develop as a result of:

Pelvic adhesions (bands of scar tissue connecting pelvic organs)
Hydrosalpinx (fluid accumulation in a blocked tube)
Chronic low-grade infection

In patients with chronic pelvic pain of uncertain origin, laparoscopy may be considered to exclude other causes, including endometriosis.

Historical Perspective

Before the widespread availability of antibiotics, acute salpingitis carried a mortality rate of approximately 1%, rising significantly in cases complicated by tubal rupture or ectopic pregnancy. While modern antibiotic therapy has dramatically improved outcomes, salpingitis remains a significant cause of preventable morbidity when diagnosis is delayed.

Diagnosis

There is no single definitive test for salpingitis. Diagnosis is typically made by a gynecologist using a combination of clinical assessment and targeted investigations, with a low threshold for treatment initiation when suspicion is raised to prevent complications.

Clinical Assessment

Medical History

Gynecological and sexual history (recent sexual partners, contraceptive use, STI history)
Menstrual history (timing of symptoms in relation to the menstrual cycle)
Recent procedures (IUD insertion, abortion, gynecological surgery)
Symptom onset, character, and associated features

Gynecological Examination

A bimanual pelvic examination is essential:

Cervical motion tenderness (CMT) (pain when the cervix is moved, the “chandelier sign”) is a hallmark finding of PID/salpingitis
Uterine tenderness: pain on palpation of the uterine body
Adnexal tenderness or mass: may indicate tubo-ovarian involvement
Abnormal discharge: purulent cervical or vaginal discharge visible on speculum examination
Enlarged or tender lymph nodes in the groin

The CDC (Centers for Disease Control and Prevention) recommends empirical treatment for PID when a sexually active young woman presents with uterine, adnexal, or cervical motion tenderness in the absence of another identifiable cause, even before laboratory results are available, because the consequences of delayed treatment are so severe.

Laboratory Tests

Complete blood count (CBC): elevated white blood cells (leukocytosis) indicates active infection
Inflammatory markers: elevated ESR and C-reactive protein (CRP) support the diagnosis of active inflammation
STI testing:
- Vaginal/cervical swab for Chlamydia trachomatis (NAAT, i.e., nucleic acid amplification test) and Neisseria gonorrhoeae (culture and NAAT)
- Mycoplasma genitalium testing where available
Urine analysis and culture: to exclude urinary tract infection as an alternative diagnosis
Pregnancy test (β-hCG): mandatory before initiating treatment; rules out ectopic pregnancy and guides safe antibiotic choice

Imaging

Transvaginal ultrasound: first-line imaging; can identify:
- Fluid in the cul-de-sac (pouch of Douglas)
- Hydrosalpinx (fluid-filled tube)
- Tubo-ovarian abscess
- Ovarian or adnexal masses
Laparoscopy: the gold standard for definitive diagnosis of salpingitis. Direct visual inspection of the tubes allows confirmation of inflammation, assessment of severity, and collection of specimens from the tube for culture. However, it is invasive and typically reserved for:
- Uncertain diagnosis after non-invasive workup
- Failure to respond to antibiotic therapy
- Suspected tubo-ovarian abscess requiring drainage
- Severe acute presentation

Fertility Assessment

In women who subsequently experience difficulty conceiving following a history of salpingitis, hysterosalpingography (HSG) (an X-ray procedure that uses contrast dye injected through the cervix) can evaluate whether the tubes remain patent (open) or have been occluded by scarring. Laparoscopic chromopertubation is the definitive surgical assessment.

Treatment

Treatment strategy depends on the severity of the infection and whether complications are present:

Antibiotic Therapy

Antibiotics are the cornerstone of treatment for salpingitis. Because PID is almost always polymicrobial (involving multiple bacterial species simultaneously), broad-spectrum antibiotic regimens covering chlamydia, gonorrhea, and anaerobic bacteria are required:

Outpatient regimens (for mild-to-moderate salpingitis):

Ceftriaxone IM (single dose) + doxycycline orally for 14 days ± metronidazole for anaerobic coverage
Alternative: oral ofloxacin or levofloxacin for 14 days ± metronidazole

Inpatient (intravenous) regimens (for severe disease, TOA, pregnancy, or failure of oral therapy):

Cefoxitin or cefotetan IV + doxycycline IV/oral
Alternative: clindamycin IV + gentamicin IV

📌 Antibiotic course duration: A minimum of 14 days of antibiotic therapy is recommended for salpingitis/PID, regardless of symptomatic improvement. Premature discontinuation significantly increases the risk of treatment failure and recurrence.

Partner Treatment

When salpingitis is caused by a sexually transmitted infection, the sexual partner(s) must be simultaneously evaluated and treated, even if asymptomatic. Failure to treat the partner results in rapid reinfection and treatment failure.

Hospitalization

Hospital admission is indicated when:

The diagnosis is uncertain and surgical emergencies must be excluded
The patient is pregnant
Symptoms are severe or the patient is systemically unwell (high fever, inability to tolerate oral medication)
A tubo-ovarian abscess is present or suspected
There is failure to respond to 72 hours of outpatient antibiotic therapy
The patient is an adolescent
Adherence to outpatient treatment cannot be ensured

Surgical Treatment

Surgery is reserved for specific situations:

Tubo-ovarian abscess that fails to respond to 48–72 hours of IV antibiotics may require laparoscopic or CT-guided percutaneous drainage
Ruptured tubo-ovarian abscess: a surgical emergency requiring immediate laparotomy
Ectopic pregnancy: surgical or medical management (methotrexate) depending on clinical stability and gestational age
Chronic pelvic pain with adhesions: laparoscopic adhesiolysis may provide relief in selected patients

Follow-Up

Patients treated for salpingitis should be reviewed:

72 hours after starting treatment to assess clinical response. Failure to improve should prompt hospitalization and re-evaluation
At completion of the antibiotic course
For repeat STI testing 3 months after treatment (high risk of reinfection)

Prevention

Prevention of salpingitis relies primarily on lifestyle choices and sexual health practices:

Primary Prevention

Use barrier contraception (condoms) consistently and correctly with all sexual partners. Condoms provide the most effective protection against STI-related salpingitis. Note that hormonal contraception (the pill) offers no protection against STIs but may reduce the risk of ascending infection by thickening cervical mucus
Reduce the number of concurrent sexual partners. The risk of acquiring an STI increases with the number of sexual contacts
Regular STI screening, particularly for chlamydia and gonorrhea in sexually active women under 25 or those with new or multiple partners, is important. Annual screening is recommended even when no symptoms are present
Prompt treatment of diagnosed STIs, along with ensuring partner notification and treatment, helps prevent reinfection

Secondary Prevention (Preventing Complications)

Seek early medical attention at the first appearance of symptoms suggestive of pelvic infection
Complete the full course of prescribed antibiotics, even if symptoms resolve before treatment is finished
Attend all follow-up appointments to confirm successful treatment

Salpingitis: Causes, Symptoms, Complications, and Treatment